242: Cardiovascular rehabilitation after a first acute coronary syndrome and the risk of recurrence and death in patients from the French MONICA registries - 01/07/14
Résumé |
Purpose |
Cardiovascular rehabilitation after an acute coronary syndrome (ACS) has become more prescribed; differences still remain in prescription rates. The aim of this work was to assess the prognostic influence of rehabilitation after ACS in the current medical practice.
Methods |
Our study was based on 2006 data from the French MONICA population-based registry which collects all cases of ACS occurring in people aged 35-74 in 3 French areas. The population consisted of 1838 incident hospitalized ACS after exclusion of those who died in the first 28 days of follow-up. The relationship between prescription of rehabilitation and composite outcome (ACS-recurrence or death) was analyzed using Cox models adjusted for living area, age, number of diseased vessels, diabetes, cardiovascular treatments and delays between symptoms and the first medical care.
Results |
There were 171 ACS-recurrences or deaths during a median follow-up of 18.1 months and 23.6% of women. The rate of rehabilitation was higher in men than in women (36 vs. 26%, p<0.0001) and decreased with age. After multivariate adjustment the risk of composite outcome occurrence was identical in men and women for STEMI but higher in women for UA/NSTEMI [adjusted HR 1.75, 95% confidence interval (1.10-2.77)]. Rehabilitation was associated with a decrease of composite outcome whatever the type of ACS [adjusted HR 0.48, (0.32-0.73)]. However a significant interaction between rehabilitation and gender has been found in UA/NSTEMI (p=0.04) but not in STEMI. A stratified analysis for gender in UA/NSTEMI showed a significant benefit of rehabilitation in women [adjusted HR 0.06, (0.01-0.44)] but not in men [adjusted HR 0.82, (0.39-1.72)].
Conclusions |
Whatever the definition of ACS, rehabilitation was associated with a reduction of ACS-recurrence and death in both sexes. However it seems to be more beneficial in women presenting UA/NSTEMI in whom it is less prescribed and in whom the rate of recurrence and death is higher.
Le texte complet de cet article est disponible en PDF.Vol 5 - N° 1
P. 82 - janvier 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
